ATC code A15

ATC code A15 Appetite stimulants is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2]^[3] Subgroup A15 is part of the anatomical group A Alimentary tract and metabolism.^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA15.^[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

This group is empty.

References

^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
^ "ATC/DDD Index 2022: code A15". WHO Collaborating Centre for Drug Statistics Methodology.
^ "ATCvet Index 2022: code QA15". WHO Collaborating Centre for Drug Statistics Methodology.

Zdroj:https://en.wikipedia.org?pojem=ATC_code_A15
Text je dostupný za podmienok Creative Commons Attribution/Share-Alike License 3.0 Unported; prípadne za ďalších podmienok. Podrobnejšie informácie nájdete na stránke Podmienky použitia.

[1] "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.

[2] World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.

[3] "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.

[4] "ATC/DDD Index 2022: code A15". WHO Collaborating Centre for Drug Statistics Methodology.

[5] "ATCvet Index 2022: code QA15". WHO Collaborating Centre for Drug Statistics Methodology.

[1]

[2]

[3]

[4]

[5]

v t e Appetite stimulants (A15)
Exogenous	Amitriptyline Clonidine Cyproheptadine Dexamethasone Dronabinol/Tetrahydrocannabinol (Cannabis) Medroxyprogesterone acetate Megestrol acetate Mirtazapine Nabilone Nandrolone Olanzapine Omega-3 fatty acid Oxandrolone Pentoxifylline Prednisone Sugars Testosterone Thalidomide
Endogenous	ACTH/Corticotropin Adiponectin Agouti-related peptide Anandamide Cortisol/Hydrocortisone Cortisone Ghrelin Melanin-concentrating hormone Melatonin Neuropeptide Y Orexin/Hypocretin

ATC code A: Alimentary tract and metabolism
A01 Stomatological preparations A02 Drugs for acid related disorders A03 Drugs for functional gastrointestinal disorders A04 Antiemetics and antinauseants A05 Bile and liver therapy A06 Drugs for constipation A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents A08 Antiobesity preparations, excluding diet products A09 Digestives, including enzymes A10 Drugs used in diabetes A11 Vitamins A12 Mineral supplements A13 Tonics A14 Anabolic agents for systemic use A15 Appetite stimulants A16 Other alimentary tract and metabolism products
Other ATC codes
A B C D G H QI J L M N P R S V

See also

References